INTERNATIONAL PATENT: INMUCELL THERAPY (US) INC. FILES APPLICATION FOR "COMBINATION THERAPY USING CELL IMMUNOTHERAPY AND AN ANTI-CANCER AGENT FOR TREATING CANCER"

GENEVA, Dec. 17 -- INMUCELL THERAPY (US) INC. (4655 EXECUTIVE DR. SUITE 200SAN DIEGO, California 92122) filed a patent application (PCT/US2025/032167) for "COMBINATION THERAPY USING CELL IMMUNOTHERAPY AND AN ANTI-CANCER AGENT FOR TREATING CANCER" on Jun 04, 2025. With publication no. WO/2025/255180, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XU, Yang (10 CORPORATE PARK STE 330IRVINE, California 92606)

Abstract: The present disclosure provides combination therapies of a population of modified immune cells and an anti...